Article Information
History
- May 30, 2024.
Article Versions
- Version 1 (September 23, 2023 - 20:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Konstantin Senkevich, MD, PhD,
- Lang Liu, MSc1,2,1,2,3,
- Chelsea X. Alvarado4,5,
- Hampton L. Leonard, MSc4,5,6,
- Mike A. Nalls, PhD,
- Global Parkinson’s Genetics Program (GP2) and
- Ziv Gan-Or, MD, PhD4,5,1,2,3,*
- 1The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada
- 2Department of Neurology and neurosurgery, McGill University, Montréal, QC, Canada, Canada
- 3Department of Human Genetics, McGill University, Montréal, QC, Canada
- 4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
- 5Data Tecnica, Washington, DC, USA, 200373
- 6DZNE Tübingen, Tübingen, Germany
- ↵*Correspondence to: Ziv Gan-Or McGill University 1033 Pine Avenue, West, Ludmer Pavilion, room 312 Montreal, QC, H3A 1A1, Phone: +1-514-398-5845 Fax. +1-514 398-8248 Email: ziv.gan-or{at}mcgill.ca
Posted May 30, 2024.
Lack of genetic evidence for NLRP3-inflammasome involvement in Parkinson’s disease pathogenesis
